Reaction profile

The FDA adverse-event record for deafness nos

311 FDA adverse-event reports reference deafness nos (VeDDRA 368). See the species, breeds, and drugs most associated with it below.

311
reports citing this reaction
5.8%
death-coded share
Dog
most-affected species
Genta/Momet/Clotrim Ear Oint
most-associated drug
Verify with FDA CVM →
311
Total Reports
18
Deaths
5.8%
Death Rate

Species Most Affected

Dog 284
Cat 26
Rabbit 1

Breeds Most Affected

Crossbred Canine/dog 36
Terrier - Yorkshire 19
Domestic Shorthair 17
Retriever - Labrador 15
Pit Bull 11
Shepherd Dog - German 11
Maltese 11
Dog (unknown) 11
Chihuahua 10
Spitz - German Pomeranian 10

Associated Drugs

Genta/Momet/Clotrim Ear Oint 70
Orbiflox/Momet/Posaco Eardrops 47
Miconazole + Polymyxin B + Prednisolone 28
Florfenicol + Mometasone Furoate + Terbinafine Hydrochloride 22
Betamethasone + Florfenicol + Terbinafine 16
Florfenicol/Terbinafine Hydrochloride/Mometasone Furoate 13
Prednisone 12
Genta/Betamet/Clotrim Ear Oint 12
Trilostane 11
Oclacitinib Maleate 10
Cefovecin 10
Enrofloxacin + Silver Sulfadiazine 8
Ear Cleaner (Unknown) 8
Florfenicol, Terbinafine, Betamethasone Acetate 8
Tresaderm Dermatological Solution 7
Ear Cleaner 7
Spinosad 6
Carprofen 6
Milbemycin Oxime + Spinosad 5
Tramadol 5

Deafness NOS Reaction Insights

311 reports name Deafness NOS; 18 recorded a death outcome (5.8% of reported events, not a population-level mortality rate). VeDDRA code: 368.

By species: Dog (284 reports), Cat (26 reports), Rabbit (1 reports). By breed: Crossbred Canine/dog (36), Terrier - Yorkshire (19), Domestic Shorthair (17).

Most co-reported drugs: Genta/Momet/Clotrim Ear Oint (70 reports), Orbiflox/Momet/Posaco Eardrops (47 reports), Miconazole + Polymyxin B + Prednisolone (28 reports), Florfenicol + Mometasone Furoate + Terbinafine Hydrochloride (22 reports).

Read these counts as reporting volume, not risk: per our methodology, co-reporting reflects temporal association captured in voluntary submissions, not proof that a drug caused this reaction. A widely-prescribed drug will rack up more raw co-reports at an identical true rate than a rarely-used one, so compare within similar-exposure products.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.